Loading…
Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages
IFN-τ is a non-cytotoxic type I IFN responsible for maternal recognition of the foetus in ruminants. IFN-τ has been found to inhibit HIV replication more strongly than human IFN-α, particularly in human monocyte-derived macrophages, without associated toxicity. Ovine IFN-τ uses the same anti-viral c...
Saved in:
Published in: | International immunology 2005-08, Vol.17 (8), p.1047-1057 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503 |
---|---|
cites | cdi_FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503 |
container_end_page | 1057 |
container_issue | 8 |
container_start_page | 1047 |
container_title | International immunology |
container_volume | 17 |
creator | Rogez-Kreuz, Christine Manéglier, Benjamin Martin, Marc Dereuddre-Bosquet, Nathalie Martal, Jacques Dormont, Dominique Clayette, Pascal |
description | IFN-τ is a non-cytotoxic type I IFN responsible for maternal recognition of the foetus in ruminants. IFN-τ has been found to inhibit HIV replication more strongly than human IFN-α, particularly in human monocyte-derived macrophages, without associated toxicity. Ovine IFN-τ uses the same anti-viral cellular pathways as human IFN-α in human macrophages, principally inhibiting the early steps of the biological cycle of HIV, preventing the integration of HIV DNA into the host-cell genome. In this study, we investigated the immunomodulatory properties of IFN-τ in human macrophages. We found that IFN-τ increased the production of IL-10 and IL-6, but not of IL-1β or tumour necrosis factor α, in unstimulated, LPS-stimulated and HIV-1/Ba-L-infected macrophages. We also found that treatment with IL-6 inhibited HIV replication. Moreover, the neutralization of IL-6 activity in the cell culture supernatants of IFN-τ-treated macrophages led to a decrease in the anti-retroviral effects of IFN-τ, suggesting that IL-6 was involved in the anti-viral activity induced by IFN-τ. By focusing on the very early steps of the biological cycle of HIV, we showed that IL-6 co-operated with IFN-τ to decrease intracellular HIV RNA levels 2 h after infection. |
doi_str_mv | 10.1093/intimm/dxh285 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68079803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>876420181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503</originalsourceid><addsrcrecordid>eNqFkU9v0zAYhy00xLrCkSuKduDm1Y7jf0eoVlapAjRAQlwsx3mzejROFyfVet_34yvNJdUmceHkw_v8ntevfgi9peSCEs1mPvS-aWbV_TpX_AWa0EIQnDMpT9CEaM6wolKdorMYbwkhLNfsFTqlXEtBGJugahl27WYHDYQ-a-tsucIi8yHr15DZpMbrobEhSyuG0FZQe-chuH22890QM-t6v_P9_m9y8Rn_eThkx0hjXddu1_YG4mv0srabCG-O7xT9WFx-n1_h1ZdPy_mHFXYFFT0GsBUnZS2oLpkiTCnhmKp5UVAlCRScUqtL6kAUJbfaFqLWsuSkLnMKjhM2Re9H77Zr7waIvWl8dLDZ2ADtEI1QROok_i9IJZNC5gfj-T_gbTt0IR1hqE4bFRUiQXiE0sExdlCbbecb2-0NJeZQkhlLMmNJiX93lA5lA9UzfWzlWehjD_dPc9v9NiL9jJurn7_Mtfj6sZizb-aaPQKQ0J5c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195038166</pqid></control><display><type>article</type><title>Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages</title><source>Oxford Journals Online</source><creator>Rogez-Kreuz, Christine ; Manéglier, Benjamin ; Martin, Marc ; Dereuddre-Bosquet, Nathalie ; Martal, Jacques ; Dormont, Dominique ; Clayette, Pascal</creator><creatorcontrib>Rogez-Kreuz, Christine ; Manéglier, Benjamin ; Martin, Marc ; Dereuddre-Bosquet, Nathalie ; Martal, Jacques ; Dormont, Dominique ; Clayette, Pascal</creatorcontrib><description>IFN-τ is a non-cytotoxic type I IFN responsible for maternal recognition of the foetus in ruminants. IFN-τ has been found to inhibit HIV replication more strongly than human IFN-α, particularly in human monocyte-derived macrophages, without associated toxicity. Ovine IFN-τ uses the same anti-viral cellular pathways as human IFN-α in human macrophages, principally inhibiting the early steps of the biological cycle of HIV, preventing the integration of HIV DNA into the host-cell genome. In this study, we investigated the immunomodulatory properties of IFN-τ in human macrophages. We found that IFN-τ increased the production of IL-10 and IL-6, but not of IL-1β or tumour necrosis factor α, in unstimulated, LPS-stimulated and HIV-1/Ba-L-infected macrophages. We also found that treatment with IL-6 inhibited HIV replication. Moreover, the neutralization of IL-6 activity in the cell culture supernatants of IFN-τ-treated macrophages led to a decrease in the anti-retroviral effects of IFN-τ, suggesting that IL-6 was involved in the anti-viral activity induced by IFN-τ. By focusing on the very early steps of the biological cycle of HIV, we showed that IL-6 co-operated with IFN-τ to decrease intracellular HIV RNA levels 2 h after infection.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/dxh285</identifier><identifier>PMID: 15976033</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>5′-OAS 2 ; 5′-oligoadenylate synthetase ; Animals ; anti-retroviral ; GAPDH glyceraldehyde 3-phosphate dehydrogenase ; HAS human serum albumin ; HIV ; HIV-1 - drug effects ; HIV-1 - immunology ; HIV-1 - physiology ; Human immunodeficiency virus 1 ; Humans ; IDV indinavir ; IFN ; IFN-τ ; IL-6 ; Immunologic Factors - pharmacology ; immunomodulation ; In Vitro Techniques ; Interferon Type I - pharmacology ; Interleukin-1 - biosynthesis ; Interleukin-10 - biosynthesis ; Interleukin-10 - pharmacology ; Interleukin-6 - biosynthesis ; Interleukin-6 - pharmacology ; macrophages ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - virology ; MIP macrophage inflammatory protein ; neomycin ; NIH National Institutes of Health ; PKR serine–threonine kinase R ; PMA phorbol myristate acetate ; Pregnancy Proteins - pharmacology ; PSN penicillin ; Recombinant Proteins - pharmacology ; RT reverse transcriptase ; Sheep ; streptomycin ; TNF tumour necrosis factor ; Tumor Necrosis Factor-alpha - biosynthesis ; Virus Replication - drug effects</subject><ispartof>International immunology, 2005-08, Vol.17 (8), p.1047-1057</ispartof><rights>Copyright Oxford University Press(England) Aug 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503</citedby><cites>FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15976033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rogez-Kreuz, Christine</creatorcontrib><creatorcontrib>Manéglier, Benjamin</creatorcontrib><creatorcontrib>Martin, Marc</creatorcontrib><creatorcontrib>Dereuddre-Bosquet, Nathalie</creatorcontrib><creatorcontrib>Martal, Jacques</creatorcontrib><creatorcontrib>Dormont, Dominique</creatorcontrib><creatorcontrib>Clayette, Pascal</creatorcontrib><title>Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages</title><title>International immunology</title><addtitle>Int. Immunol</addtitle><description>IFN-τ is a non-cytotoxic type I IFN responsible for maternal recognition of the foetus in ruminants. IFN-τ has been found to inhibit HIV replication more strongly than human IFN-α, particularly in human monocyte-derived macrophages, without associated toxicity. Ovine IFN-τ uses the same anti-viral cellular pathways as human IFN-α in human macrophages, principally inhibiting the early steps of the biological cycle of HIV, preventing the integration of HIV DNA into the host-cell genome. In this study, we investigated the immunomodulatory properties of IFN-τ in human macrophages. We found that IFN-τ increased the production of IL-10 and IL-6, but not of IL-1β or tumour necrosis factor α, in unstimulated, LPS-stimulated and HIV-1/Ba-L-infected macrophages. We also found that treatment with IL-6 inhibited HIV replication. Moreover, the neutralization of IL-6 activity in the cell culture supernatants of IFN-τ-treated macrophages led to a decrease in the anti-retroviral effects of IFN-τ, suggesting that IL-6 was involved in the anti-viral activity induced by IFN-τ. By focusing on the very early steps of the biological cycle of HIV, we showed that IL-6 co-operated with IFN-τ to decrease intracellular HIV RNA levels 2 h after infection.</description><subject>5′-OAS 2</subject><subject>5′-oligoadenylate synthetase</subject><subject>Animals</subject><subject>anti-retroviral</subject><subject>GAPDH glyceraldehyde 3-phosphate dehydrogenase</subject><subject>HAS human serum albumin</subject><subject>HIV</subject><subject>HIV-1 - drug effects</subject><subject>HIV-1 - immunology</subject><subject>HIV-1 - physiology</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>IDV indinavir</subject><subject>IFN</subject><subject>IFN-τ</subject><subject>IL-6</subject><subject>Immunologic Factors - pharmacology</subject><subject>immunomodulation</subject><subject>In Vitro Techniques</subject><subject>Interferon Type I - pharmacology</subject><subject>Interleukin-1 - biosynthesis</subject><subject>Interleukin-10 - biosynthesis</subject><subject>Interleukin-10 - pharmacology</subject><subject>Interleukin-6 - biosynthesis</subject><subject>Interleukin-6 - pharmacology</subject><subject>macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - virology</subject><subject>MIP macrophage inflammatory protein</subject><subject>neomycin</subject><subject>NIH National Institutes of Health</subject><subject>PKR serine–threonine kinase R</subject><subject>PMA phorbol myristate acetate</subject><subject>Pregnancy Proteins - pharmacology</subject><subject>PSN penicillin</subject><subject>Recombinant Proteins - pharmacology</subject><subject>RT reverse transcriptase</subject><subject>Sheep</subject><subject>streptomycin</subject><subject>TNF tumour necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>Virus Replication - drug effects</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v0zAYhy00xLrCkSuKduDm1Y7jf0eoVlapAjRAQlwsx3mzejROFyfVet_34yvNJdUmceHkw_v8ntevfgi9peSCEs1mPvS-aWbV_TpX_AWa0EIQnDMpT9CEaM6wolKdorMYbwkhLNfsFTqlXEtBGJugahl27WYHDYQ-a-tsucIi8yHr15DZpMbrobEhSyuG0FZQe-chuH22890QM-t6v_P9_m9y8Rn_eThkx0hjXddu1_YG4mv0srabCG-O7xT9WFx-n1_h1ZdPy_mHFXYFFT0GsBUnZS2oLpkiTCnhmKp5UVAlCRScUqtL6kAUJbfaFqLWsuSkLnMKjhM2Re9H77Zr7waIvWl8dLDZ2ADtEI1QROok_i9IJZNC5gfj-T_gbTt0IR1hqE4bFRUiQXiE0sExdlCbbecb2-0NJeZQkhlLMmNJiX93lA5lA9UzfWzlWehjD_dPc9v9NiL9jJurn7_Mtfj6sZizb-aaPQKQ0J5c</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Rogez-Kreuz, Christine</creator><creator>Manéglier, Benjamin</creator><creator>Martin, Marc</creator><creator>Dereuddre-Bosquet, Nathalie</creator><creator>Martal, Jacques</creator><creator>Dormont, Dominique</creator><creator>Clayette, Pascal</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200508</creationdate><title>Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages</title><author>Rogez-Kreuz, Christine ; Manéglier, Benjamin ; Martin, Marc ; Dereuddre-Bosquet, Nathalie ; Martal, Jacques ; Dormont, Dominique ; Clayette, Pascal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>5′-OAS 2</topic><topic>5′-oligoadenylate synthetase</topic><topic>Animals</topic><topic>anti-retroviral</topic><topic>GAPDH glyceraldehyde 3-phosphate dehydrogenase</topic><topic>HAS human serum albumin</topic><topic>HIV</topic><topic>HIV-1 - drug effects</topic><topic>HIV-1 - immunology</topic><topic>HIV-1 - physiology</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>IDV indinavir</topic><topic>IFN</topic><topic>IFN-τ</topic><topic>IL-6</topic><topic>Immunologic Factors - pharmacology</topic><topic>immunomodulation</topic><topic>In Vitro Techniques</topic><topic>Interferon Type I - pharmacology</topic><topic>Interleukin-1 - biosynthesis</topic><topic>Interleukin-10 - biosynthesis</topic><topic>Interleukin-10 - pharmacology</topic><topic>Interleukin-6 - biosynthesis</topic><topic>Interleukin-6 - pharmacology</topic><topic>macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - virology</topic><topic>MIP macrophage inflammatory protein</topic><topic>neomycin</topic><topic>NIH National Institutes of Health</topic><topic>PKR serine–threonine kinase R</topic><topic>PMA phorbol myristate acetate</topic><topic>Pregnancy Proteins - pharmacology</topic><topic>PSN penicillin</topic><topic>Recombinant Proteins - pharmacology</topic><topic>RT reverse transcriptase</topic><topic>Sheep</topic><topic>streptomycin</topic><topic>TNF tumour necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rogez-Kreuz, Christine</creatorcontrib><creatorcontrib>Manéglier, Benjamin</creatorcontrib><creatorcontrib>Martin, Marc</creatorcontrib><creatorcontrib>Dereuddre-Bosquet, Nathalie</creatorcontrib><creatorcontrib>Martal, Jacques</creatorcontrib><creatorcontrib>Dormont, Dominique</creatorcontrib><creatorcontrib>Clayette, Pascal</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rogez-Kreuz, Christine</au><au>Manéglier, Benjamin</au><au>Martin, Marc</au><au>Dereuddre-Bosquet, Nathalie</au><au>Martal, Jacques</au><au>Dormont, Dominique</au><au>Clayette, Pascal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages</atitle><jtitle>International immunology</jtitle><addtitle>Int. Immunol</addtitle><date>2005-08</date><risdate>2005</risdate><volume>17</volume><issue>8</issue><spage>1047</spage><epage>1057</epage><pages>1047-1057</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>IFN-τ is a non-cytotoxic type I IFN responsible for maternal recognition of the foetus in ruminants. IFN-τ has been found to inhibit HIV replication more strongly than human IFN-α, particularly in human monocyte-derived macrophages, without associated toxicity. Ovine IFN-τ uses the same anti-viral cellular pathways as human IFN-α in human macrophages, principally inhibiting the early steps of the biological cycle of HIV, preventing the integration of HIV DNA into the host-cell genome. In this study, we investigated the immunomodulatory properties of IFN-τ in human macrophages. We found that IFN-τ increased the production of IL-10 and IL-6, but not of IL-1β or tumour necrosis factor α, in unstimulated, LPS-stimulated and HIV-1/Ba-L-infected macrophages. We also found that treatment with IL-6 inhibited HIV replication. Moreover, the neutralization of IL-6 activity in the cell culture supernatants of IFN-τ-treated macrophages led to a decrease in the anti-retroviral effects of IFN-τ, suggesting that IL-6 was involved in the anti-viral activity induced by IFN-τ. By focusing on the very early steps of the biological cycle of HIV, we showed that IL-6 co-operated with IFN-τ to decrease intracellular HIV RNA levels 2 h after infection.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>15976033</pmid><doi>10.1093/intimm/dxh285</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8178 |
ispartof | International immunology, 2005-08, Vol.17 (8), p.1047-1057 |
issn | 0953-8178 1460-2377 |
language | eng |
recordid | cdi_proquest_miscellaneous_68079803 |
source | Oxford Journals Online |
subjects | 5′-OAS 2 5′-oligoadenylate synthetase Animals anti-retroviral GAPDH glyceraldehyde 3-phosphate dehydrogenase HAS human serum albumin HIV HIV-1 - drug effects HIV-1 - immunology HIV-1 - physiology Human immunodeficiency virus 1 Humans IDV indinavir IFN IFN-τ IL-6 Immunologic Factors - pharmacology immunomodulation In Vitro Techniques Interferon Type I - pharmacology Interleukin-1 - biosynthesis Interleukin-10 - biosynthesis Interleukin-10 - pharmacology Interleukin-6 - biosynthesis Interleukin-6 - pharmacology macrophages Macrophages - drug effects Macrophages - immunology Macrophages - virology MIP macrophage inflammatory protein neomycin NIH National Institutes of Health PKR serine–threonine kinase R PMA phorbol myristate acetate Pregnancy Proteins - pharmacology PSN penicillin Recombinant Proteins - pharmacology RT reverse transcriptase Sheep streptomycin TNF tumour necrosis factor Tumor Necrosis Factor-alpha - biosynthesis Virus Replication - drug effects |
title | Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T20%3A30%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20IL-6%20in%20the%20anti-human%20immunodeficiency%20virus%20activity%20of%20IFN-%CF%84%20in%20human%20macrophages&rft.jtitle=International%20immunology&rft.au=Rogez-Kreuz,%20Christine&rft.date=2005-08&rft.volume=17&rft.issue=8&rft.spage=1047&rft.epage=1057&rft.pages=1047-1057&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/dxh285&rft_dat=%3Cproquest_cross%3E876420181%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-eead50bf619b3803886c38f5441870e4511a9b1ce64b5a9a46f97b50fb21ec503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195038166&rft_id=info:pmid/15976033&rfr_iscdi=true |